Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.47
-0.27 (-1.97%)
At close: May 13, 2025, 4:00 PM
13.50
+0.03 (0.22%)
Pre-market: May 14, 2025, 5:24 AM EDT
Keros Therapeutics Employees
Keros Therapeutics had 169 employees as of December 31, 2024. The number of employees increased by 33 or 24.26% compared to the previous year.
Employees
169
Change (1Y)
33
Growth (1Y)
24.26%
Revenue / Employee
$1,270,491
Profits / Employee
$24,923
Market Cap
547.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KROS News
- 1 day ago - ADAR1 Capital Management Releases Investor Presentation Outlining Its Rationale for Withholding Votes From Directors Dr. Mary Ann Gray and Dr. Alpna Seth - PRNewsWire
- 1 day ago - Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference - GlobeNewsWire
- 5 days ago - Keros Reinforces Commitment to Maximizing Stockholder Value - GlobeNewsWire
- 5 days ago - ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders - PRNewsWire
- 7 days ago - Keros Therapeutics Reports Recent First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Benzinga
- 4 weeks ago - Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - Benzinga
- 4 weeks ago - Keros Therapeutics adopts 'poison pill' plan - Reuters